Dendritic Cells Armed With Anti-CD3 mAbs Reduce Pulmonary Metastases, Prolong Survival, and Engender Antitumor Effector Cells Demonstrable by Adoptive Transfer-Reference-Cited by-同舟云学术

Dendritic Cells Armed With Anti-CD3 mAbs Reduce Pulmonary Metastases, Prolong Survival, and Engender Antitumor Effector Cells Demonstrable by Adoptive Transfer

Published:2000-12 Issue:10 Volume:7 Page:771-776
ISSN:1068-9265
Container-title:Annals of Surgical Oncology
language:en
Short-container-title:Ann Surg Oncol

Author:

Maluccio Mary A.,Rao Jyosthna,Sharma Vijay,Lagman Milagros,Suthanthiran Manikkam

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Surgery

Link

http://link.springer.com/content/pdf/10.1007/s10434-000-0771-9.pdf

Reference18 articles.

1. Urban JL, Schreiber H. Tumor antigens. Annu Rev Immunol 1992; 10:617?644.

2. Larsen CP, Ritchie SC, Pearson TC, Linsley PS, Lowry RP. Functional expression of the costimulatory molecule, B7/BB1 on murine dendritic cell population. J Exp Med 1992;176:1215?1220.

3. Zitvogel L, Mayordomo J, Tjanddrawan T, DeLeo AB, Clarke MR, Lotze MT, Storkus WJ. Therapy of murine tumors with tumor-peptide pulsed dendritic cells: dependence on T-cells, B7 costimulation, and T-helper cell 1-associated cytokines. J Exp Med 1996;183:87?97.

4. Wong C, Morse M, Nair SK. Induction of primary, human antigen specific cytotoxic T lymphocytes in vitro using dendritic cells pulsed with peptides. J Immunotherapy 1998;21:32?40.

5. McArthur JG, Mulligan RC. Induction of protective immunity by gene modified dendritic cells. J Immunotherapy 1998;21:41?47.

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Expression of dendritic cell phenotypic antigens in cervical lymph nodes of patients with hypopharyngeal and laryngeal carcinoma;The Journal of Laryngology & Otology;2009-05

2. Phenotypic Characterization and Distribution of Dendritic Cells in Parotid Gland Tumors;ORL;2004

3. Therapeutic vaccination against metastatic renal cell carcinoma by autologous dendritic cells: preclinical results and outcome of a first clinical phase I/II trial;Cancer Immunology, Immunotherapy;2002-12-01